201
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Safety and efficacy of HepaSphere 50–100 μm in the treatment of hepatocellular carcinoma

, , , , , , , , , , & show all
Pages 212-219 | Received 25 Jan 2016, Accepted 16 Jan 2017, Published online: 14 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Guangsheng Zhao, Song Liu, Songbai Chen, Zhizhong Ren, Chuang Li, Jie Bian, Jianlin Wu, Jun Zhou & Yuewei Zhang. (2021) Assessment of efficacy and safety by CalliSpheres versus HepaSpheres for drug-eluting bead transarterial chemoembolization in unresectable large hepatocellular carcinoma patients. Drug Delivery 28:1, pages 1356-1362.
Read now

Articles from other publishers (3)

Xin Li, Wenxia Lv, Weiqi Yang, Yinfeng Guo, Jianwen Huang, Wenyi Liang, Yugang Huang, Aiping Qin, Xingmei Deng, Xufeng Li, Mianrong Chen, Hainan Yang, Lu Liang & Lingran Du. (2023) Poly (hydroxyethyl methacrylate - acrylic acid) microspheres loaded with magnetically responsive Fe3O4 nanoparticles for arterial embolization, drug loading and MRI detection. Journal of Drug Delivery Science and Technology 79, pages 103993.
Crossref
K. Malagari, H. Moschouris, Th. Kiakidis, S. Harward, A. Kelekis, S. Vrakas, D. Koundouras, D. Filipiadis, G. Glantzounis, E. Emmanouil, A. Chatziioannou, V. Vergadis, I. Elefsiniotis, J. Koskinas, S. Dourakis & N. Kelekis. (2019) Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30–60 μm: Results from a Single-Centre Prospective Phase II Trial. CardioVascular and Interventional Radiology 42:11, pages 1551-1562.
Crossref
Jian-Ying Zeng, Xiang-Hao Piao, Zhong-Yuan Zou, Qing-Feng Yang, Zi-Lin Qin, Ji-Bing Chen, Liang Zhou, Li-Zhi Niu & Jian-Guo Liu. (2018) Cryoablation with drug-loaded bead embolization in the treatment of unresectable hepatocellular carcinoma: safety and efficacy analysis. Oncotarget 9:7, pages 7557-7566.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.